Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
10:51am, Thursday, 26'th Feb 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer
08:24am, Thursday, 26'th Feb 2026
Veteran M&A and transformation leader from Danaher and Patheon joins the Quest Diagnostics executive team SECAUCUS, N.J., Feb. 26, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provi
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference
10:00am, Wednesday, 25'th Feb 2026
SECAUCUS, N.J., Feb. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President & Chief Finan
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
10:41am, Tuesday, 24'th Feb 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Insider Selling: Quest Diagnostics (NYSE:DGX) SVP Sells $196,227.14 in Stock
05:52am, Monday, 23'rd Feb 2026
Quest Diagnostics Incorporated (NYSE: DGX - Get Free Report) SVP Patrick Plewman sold 958 shares of the business's stock in a transaction dated Thursday, February 19th. The shares were sold at an aver
Compass Wealth Management LLC Makes New Investment in Quest Diagnostics Incorporated $DGX
04:08am, Saturday, 21'st Feb 2026
Compass Wealth Management LLC bought a new position in Quest Diagnostics Incorporated (NYSE: DGX) in the undefined quarter, according to the company in its most recent filing with the Securities and E
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?
10:16am, Wednesday, 11'th Feb 2026
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Quest Diagnostics CEO on using blood testing for Alzheimer's diagnosis
04:34pm, Tuesday, 10'th Feb 2026
Quest Diagnostics CEO Jim Davis says the company's Alzheimer's testing through blood work can help disagnons the disease a lot sooner and get patients into specialist earlier.
Consolidated Revenues: $2.81 billion, up 7.1% year-over-year.Organic Revenue Growth: 6.4% in the fourth quarter.Diagnostic Information Services Revenue Growth:
Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript
12:14pm, Tuesday, 10'th Feb 2026
Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript
Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up
11:45am, Tuesday, 10'th Feb 2026
DGX tops Q4 EPS and revenue estimates as volumes rise, shares jump premarket, and 2026 guidance points to steady growth.
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
10:51am, Tuesday, 10'th Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates
08:55am, Tuesday, 10'th Feb 2026
Quest Diagnostics (DGX) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.35 per share. This compares to earnings of $2.23 per share a year ago.
Quest Diagnostics forecasts 2026 profit, revenue above estimates on lab test demand
08:03am, Tuesday, 10'th Feb 2026
Quest Diagnostics on Tuesday forecast 2026 profit and revenue above Wall Street estimates after beating expectations for fourth-quarter results on strong demand for its diagnostic tests.
Fourth quarter revenues of $2.81 billion, up 7.1% from 2024 Fourth quarter reported diluted earnings per share ("EPS") of $2.18, up 11.8% from 2024; and adjusted diluted EPS of $2.42, up 8.5% from 202
